Tazobactum%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520piperacillin

# Piperacillin/Tazobactam ## Overview Piperacillin/tazobactam is a combination antibiotic consisting of piperacillin, a broad-spectrum penicillin antibiotic, and tazobactam, a beta-lactamase inhibitor. ## Primary Indications * Complicated intra-abdominal infections * Complicated skin and skin structure infections * Community-acquired pneumonia * Nosocomial pneumonia * Bacterial meningitis (when documented or suspected to be caused by susceptible organisms) ## Adult Dosing * **Standard Dose:** 3.375 grams (piperacillin 3 grams / tazobactam 0.375 grams) intravenously every 6 hours. * **Higher Doses for Severe Infections:** 4.5 grams (piperacillin 4 grams / tazobactam 0.5 grams) intravenously every 6 or 8 hours. Higher doses are often used for hospital-acquired pneumonia or other severe infections. Dosing interval may be extended to 8 hours in some situations, particularly for specific pathogens or depending on clinical response and local susceptibility patterns. * **Duration of Therapy:** Typically 7 to 14 days, guided by severity of infection, clinical response, and pathogen susceptibility. ## Pediatric Dosing * **Children 2 months and older:** Dosing is based on piperacillin weight. * **Mild to moderate infections:** 90 mg/kg (piperacillin component) per dose intravenously every 8 hours. * **Severe infections:** 120 mg/kg (piperacillin component) per dose intravenously every 6 hours. * **Maximum Dose:** Do not exceed the maximum adult dose of 4.5 grams every 6 hours. * **Infants < 2 months:** Dosing is not well established and should be determined by a pediatric infectious disease specialist. ## Dose Adjustments * **Renal Impairment:** * CrCl > 20 mL/min: No dose adjustment generally required. * CrCl ≤ 20 mL/min: Reduce the dose by 33% to 50% and/or extend the dosing interval. Consult specific guidelines for precise recommendations. * **Hepatic Impairment:** No dose adjustment is typically required. ## Contraindications * Known history of hypersensitivity to piperacillin, tazobactam, any other beta-lactam antibiotics, or any component of the formulation. ## Adverse Effects * **Common:** Diarrhea, nausea, vomiting, rash, headache, insomnia. * **Serious:** * Hypersensitivity reactions (including anaphylaxis) * Clostridioides difficile-associated diarrhea * Seizures (especially with high doses or renal impairment) * Hematologic changes (neutropenia, thrombocytopenia, leukopenia) * Hepatotoxicity * Interstitial nephritis ## Key Drug Interactions * **Probenecid:** May increase and prolong piperacillin serum concentrations. * **Neuromuscular blocking agents (e.g., vecuronium):** Piperacillin may prolong the neuromuscular blockade. * **Warfarin:** May decrease the effect of warfarin. Monitor INR closely. * **Methotrexate:** Piperacillin may decrease methotrexate clearance. Monitor methotrexate levels. ## Monitoring * **Renal function:** Especially in patients with pre-existing renal impairment or those receiving concomitant nephrotoxic agents. * **Liver function tests:** Baseline and periodically. * **Complete blood counts:** Monitor for hematologic changes, particularly with prolonged therapy. * **Signs and symptoms of C. difficile infection:** Diarrhea, abdominal cramping, fever. * **Signs and symptoms of hypersensitivity reactions.** * **Clinical response to treatment:** Fever, white blood cell count, signs of infection. ## Clinical Pearls * Piperacillin/tazobactam is a potent antibiotic with a broad spectrum of activity, but resistance mechanisms (e.g., extended-spectrum beta-lactamases) are increasing. * Dosing frequency may depend on the severity of infection and the susceptibility of the infecting organism. Continuous or extended infusions are sometimes used to achieve higher drug concentrations, particularly for severe infections or organisms with reduced susceptibility. * The choice of dose and duration should be guided by institutional antibiograms and clinical judgment. * When preparing and administering, ensure adequate hydration and consider risk factors for potential adverse effects like seizures. *** *This information is intended for healthcare professionals and does not substitute for professional medical advice. Always verify current prescribing information and consult with a qualified healthcare provider before making any treatment decisions.*